Critchlow M A, Bland Y S, Ashhurst D E
Department of Anatomy, St George's Hospital Medical School, Tooting, London, UK.
J Cell Sci. 1994 Feb;107 ( Pt 2):499-516. doi: 10.1242/jcs.107.2.499.
Additional bone and cartilage are formed if transforming growth factor-beta is injected into the periosteum of calvariae or long bones. To investigate this further, transforming growth factor-beta 2 was injected into the periosteum of the tibia of 3-day-old, 3-month-old and 2-year-old rabbits. In all instances, there was an increase in proliferation of the cells of the cambial layer of the periosteum, that is, the osteoprogenitor cells, and breakdown of the fibrous layer. Oedema was induced in the surrounding connective tissues. Over the experimental period the normal neonatal tibia is undergoing rapid growth; there is periosteal bone formation and endosteal resorption. In the experimental neonatal tibiae, an increase in periosteal bone formation is seen after three injections of 20 ng of transforming growth factor-beta 2, which is accompanied by cartilage after five injections; the amounts of induced bone and cartilage increase with the number of injections. The chondrocytes hypertrophy after 4 days and the cartilage is replaced by bone endochondrally. In contrast, after seven injections of 20 ng transforming growth factor-beta 2, there is only a small amount of new bone on the 3-month-old tibia and none on the 2-year-old tibia. One day after seven injections of 200 ng transforming growth factor-beta 2, there is a small amount of bone formation, while seven days after cartilage is found as small discrete nodules on the 3-month-old tibia, but as small areas within the bone on the 2-year-old tibia. It is concluded that the primary effect of transforming growth factor-beta 2 in this experimental model is to increase the proliferative rate of the osteoprogenitor cells in the periosteum. It is argued that transforming growth factor-beta 2 does not initiate osteoblastic or chondrocytic differentiation of osteoprogenitor cells. It is suggested that their differentiation is controlled by the local environment, in particular, the vascularity and locally circulating growth factors.
如果将转化生长因子-β注入颅盖骨或长骨的骨膜中,会形成额外的骨和软骨。为了进一步研究这一现象,将转化生长因子-β2注入3日龄、3月龄和2岁兔子的胫骨骨膜中。在所有情况下,骨膜生发层的细胞(即骨祖细胞)增殖增加,纤维层分解。周围结缔组织出现水肿。在实验期间,正常新生兔的胫骨正在快速生长;有骨膜骨形成和骨髓腔内吸收。在实验性新生兔胫骨中,注射3次20纳克转化生长因子-β2后可见骨膜骨形成增加,注射5次后伴有软骨形成;诱导形成的骨和软骨量随注射次数增加。软骨细胞在4天后肥大,软骨通过软骨内成骨被骨替代。相比之下,在3月龄兔子的胫骨上,注射7次20纳克转化生长因子-β2后只有少量新骨形成,在2岁兔子的胫骨上则没有新骨形成。注射7次200纳克转化生长因子-β2后1天,有少量骨形成,而7天后,在3月龄兔子的胫骨上发现软骨为小的离散结节,在2岁兔子的胫骨上则为骨内的小区域。得出的结论是,在该实验模型中,转化生长因子-β2的主要作用是提高骨膜中骨祖细胞的增殖率。有人认为转化生长因子-β2不会启动骨祖细胞的成骨或软骨细胞分化。有人提出,它们的分化受局部环境控制,特别是血管供应和局部循环生长因子。